Legal & General Group
BOLD

Legal & General Group’s Boundless Bio BOLD Stock Holding History

Legal & General Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,449
Closed -$2.22K – 3570
2025
Q1 		$2.22K Hold
1,449
– – ﹤0.01% 3349
2024
Q4 		$4.21K Buy
1,449
+400
+38% +$1.17K ﹤0.01% 3351
2024
Q3 		$3.63K Buy
+1,049
New +$3.8K ﹤0.01% 3381

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's BOLD Position: Q2 2025 in Review

Legal & General Group sold out of Boundless Bio (BOLD) in Q2 2025, closing a stake of 1,449 shares — an estimated $2.22K sold.

Legal & General Group first reported a position in BOLD in Q3 2024 and held it in 3 quarters. The position peaked at $4.21K in Q4 2024. 44 funds tracked by Wall St. Rank hold BOLD as of Q2 2025.

  • Legal & General Group reported no remaining Boundless Bio position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 1,449 Boundless Bio shares in Q2 2025, an estimated $2.22K.
  • Legal & General Group first reported a position in Boundless Bio in Q3 2024 and held it in 3 quarters.
  • Legal & General Group's Boundless Bio position peaked at $4.21K in Q4 2024.
  • 44 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.